tenk.fyi

Allogene Therapeutics, Inc.

ALLONasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$0

100.0% YoY

Net Income

-$190.9M

25.9% YoY

EPS

$-0.87

34.1% YoY

Cash

$51.7M

31.3% YoY

FY 2025 · As of 2025-12-31